Orchestra
PrivateLast Round
Debt
Apr 1, 2026
Total Funding Raised
$20M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Orchestra is a business/productivity software company that has developed a life sciences R&D management platform designed to optimize the planning, execution, and monitoring of complex drug development programs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Workflow Automation
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Orchestra Comparables
Compare Orchestra with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kaleidoscope | 57% | |
| Perceptic | 43% | |
| Weave Bio | 41% |
Orchestra Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Apr 1, 2026 | ||||
| Seed | Aug 4, 2025 |
Key People
Founding team and executive leadership
Orchestra Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Seed |
| Haystack | Seed |
| Definition Capital | Seed |
| 8VC | Seed |
| Medtronic | Debt |
| Insight Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 19, 2026
Open roles increased to 17, 89% of headcount.
- Oct 6, 2026
Open roles increased to 13, representing 68% of headcount.
Recent news
Latest coverage and updates
- receives_financingOct 21, 2026
Before its acquisition, Orchestra raises approximately $20M in total funding from Andreessen Horowitz, Definition Capital, Insight Partners, and 8VC, according to Caplight data.
- integrates_withOct 20, 2026
Orchestra is set to integrate with ROSALIND, Inc., combining study- and campaign-tracking capabilities with GPT-Rosalind’s biology and chemistry answers and Rosalind Workbench’s connections to lab tools and data; no integration timeline is disclosed.
Orchestra Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Orchestra's valuation, stock price, and market status.
Is Orchestra a public or private company?
Orchestra is a private company.
What is the current stock price of Orchestra?
Orchestra is a private company, so its shares have no public market price. Caplight tracks Orchestra's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Orchestra worth (valuation)?
Valuation information for Orchestra is not publicly available.
Can I buy Orchestra stock?
Orchestra shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Orchestra's last funding round?
Orchestra's most recent funding round was Debt on April 1, 2026.
Who are the main investors in Orchestra?
Key investors in Orchestra include Andreessen Horowitz, Haystack, Definition Capital, 8VC, Medtronic.
Will Orchestra IPO soon?
No public IPO plans have been announced for Orchestra.
How can I track Orchestra secondary market activity?
Caplight tracks bids, offers, and trades in Orchestra's shares on secondary markets.